Christopher Raymond

Work

Analyst Christopher Raymond works at PIPER SANDLER and is focused on the Healthcare sector with 879 price targets and ratings documented since 2008 spanning on 33 stocks. Analyst's average stock valuation to be materialised ratio is 46.78% with an average time for price targets to be met of 177.57 days.

Most recent stock forecast was given on ARDX, Ardelyx, Inc at 17-Nov-2022.

Christopher Raymond best performing recommendations are on BOLD.
The best stock recommendation documented was for DCPH (DECIPHERA PHARMACEUTICALS, INC) at 6/1/2018. The price target of $35 was fulfilled within 3 days with a profit of $9.09 (35.08%) receiving and performance score of 116.94.

Average potential price target upside

ABBV ACRS AIMT AKBA ALVR ALXN AMAG AMGN ARDX BIIB BMRN COGT DCPH GRAY INO ONCR RARE REGN APTX BPMC CELG INZY MGTX OTIC RIGL BOLD CBIO KNTE PRVL SLDB XLRN BCRX BHVN
ABBV ACRS AIMT AKBA ALVR ALXN AMAG AMGN ARDX BIIB BMRN COGT DCPH GRAY INO ONCR RARE REGN APTX BPMC CELG INZY MGTX OTIC RIGL BOLD CBIO KNTE PRVL SLDB XLRN BCRX BHVN